Skip to main content
UniHealth

Doctor search

Meghan Kathleen Mcauliffe, NP

Nurse Practitioner · Stanford

NPI 1184990699

Medicare standing
Clear
Enrolled, allowed to bill and order, not excluded
Plans that list them
Not verified
Not the same as out of network.
Office
1
Since medical school
15 years
Graduated 2011

Offices

1 location · Stanford Health Care · 3,152 clinicians in this group

Looking this up.

Hospitals listed: Stanford Health Care. That is not proof they admit you there this week.

Plan participation

Not verified

We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Meghan Kathleen Mcauliffe’s office at (650) 723-4000 to ask if they take your plan before you enroll.

State licence records

1 licence

  • Illinois 209012838Advanced Practice Registered Nurse · since 2015 · expires 2028-05-31
    ActiveNo board action on this licenceCheck it with the state

We check Colorado, Delaware, Florida, Illinois, Maryland, New Jersey, New York, Tennessee, Texas, Virginia, Washington, plus California above. A state that is not in this list has not been checked, which is not the same as clear.

Hospitals they work in

1 hospital

These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.

  • Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend it
    Overall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for Stanford Health Care

Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.

Every scored measure at Stanford Health Care
Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths5.31 (4.24 to 6.37) · 8,661 casesWorseJul 2022 – Jun 2024
Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits14.1 (12.7 to 15.7) · 2,191 casesWorseJan 2024 – Dec 2024
Postoperative respiratory failure rateComplications and deaths4.08 (1.95 to 6.21) · 5,296 casesBetterJul 2022 – Jun 2024
Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections0.317BetterOct 2024 – Sep 2025
Clostridium Difficile (C.Diff)Infections0.446BetterOct 2024 – Sep 2025
SSI - Colon SurgeryInfections0.241BetterOct 2024 – Sep 2025
Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits0.7 (0.6 to 0.9) · 3,348 casesBetterJan 2024 – Dec 2024
Abdominopelvic accidental puncture or laceration rateComplications and deaths1.06 (0.45 to 1.67) · 5,374 casesNo differentJul 2022 – Jun 2024
CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths0.86 (0.72 to 1)No differentJul 2022 – Jun 2024
Death rate among surgical inpatients with serious treatable complicationsComplications and deaths166.09 (137.88 to 194.3) · 470 casesNo differentJul 2022 – Jun 2024
Death rate for CABG surgery patientsComplications and deaths1.1 · 192 casesNoneJul 2022 – Jun 2025
Death rate for COPD patientsComplications and deaths6.4 · 146 casesNoneJul 2022 – Jun 2025
Death rate for heart attack patientsComplications and deaths9.7 · 253 casesNoneJul 2022 – Jun 2025
Death rate for heart failure patientsComplications and deaths6.3 · 880 casesNoneJul 2022 – Jun 2025
Death rate for pneumonia patientsComplications and deaths10.3 · 935 casesNoneJul 2022 – Jun 2025
Death rate for stroke patientsComplications and deaths8.7 · 501 casesNoneJul 2023 – Jun 2025
Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths2.1 · 7,730 casesNoneJul 2024 – Jun 2025
Iatrogenic pneumothorax rateComplications and deaths0.13 (0 to 0.27) · 20,799 casesNo differentJul 2022 – Jun 2024
In-hospital fall-associated fracture rateComplications and deaths0.28 (0.14 to 0.43) · 23,182 casesNo differentJul 2022 – Jun 2024
Postoperative acute kidney injury requiring dialysis rateComplications and deaths0.94 (0.2 to 1.68) · 5,694 casesNo differentJul 2022 – Jun 2024
Postoperative hemorrhage or hematoma rateComplications and deaths2.36 (1.54 to 3.19) · 7,846 casesNo differentJul 2022 – Jun 2024
Postoperative sepsis rateComplications and deaths5.2 (3.76 to 6.64) · 5,603 casesNo differentJul 2022 – Jun 2024
Postoperative wound dehiscence rateComplications and deaths1.38 (0.23 to 2.53) · 2,211 casesNo differentJul 2022 – Jun 2024
Pressure ulcer rateComplications and deaths0.52 (0.21 to 0.83) · 19,915 casesNo differentJul 2022 – Jun 2024
Rate of complications for hip/knee replacement patientsComplications and deaths3.6 · 416 casesNoneApr 2023 – Mar 2025
Central Line Associated Bloodstream Infection (ICU + select Wards)Infections0.869No differentOct 2024 – Sep 2025
MRSA BacteremiaInfections0.857No differentOct 2024 – Sep 2025
SSI - Abdominal HysterectomyInfections0.368No differentOct 2024 – Sep 2025
Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits16.2 · 247 casesNoneJul 2023 – Jun 2025
Heart failure (HF) 30-Day Readmission RateUnplanned return visits20.5 · 1,021 casesNoneJul 2023 – Jun 2025
Hospital return days for heart attack patientsUnplanned return visits47.8 · 258 casesNoneJul 2022 – Jun 2025
Hospital return days for heart failure patientsUnplanned return visits-1.6 · 990 casesNoneJul 2022 – Jun 2025
Hospital return days for pneumonia patientsUnplanned return visits20.8 · 976 casesNoneJul 2022 – Jun 2025
Pneumonia (PN) 30-Day Readmission RateUnplanned return visits16.5 · 959 casesNoneJul 2023 – Jun 2025
Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits5.2 (4.4 to 6.2) · 2,191 casesNo differentJan 2024 – Dec 2024
Rate of readmission after hip/knee replacementUnplanned return visits5.1 · 425 casesNoneJul 2023 – Jun 2025
Rate of readmission for CABGUnplanned return visits9.6 · 158 casesNoneJul 2023 – Jun 2025
Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits19.6 · 183 casesNoneJul 2023 – Jun 2025
Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits12.7 (10.4 to 15.4) · 4,578 casesNo differentJan 2022 – Dec 2024

What patients said (6,810 patients answered, 25% of those asked)

Patient survey stars by topic at Stanford Health Care
Cleanliness4
Nurse communication4
Doctor communication4
Communication about medicines3
Discharge information4
Overall hospital rating4
Quietness2
Recommend hospital5
Share of patients giving the best answer at Stanford Health Care
Room was "always" clean75%
Nurses "always" communicated well82%
Doctors "always" communicated well81%
Staff "always" explained63%
Yes, staff "did" give patients this information89%
Yes, staff "did" give patients information about help after discharge89%
Doctors "always" explained things so they could understand76%
Doctors "always" listened carefully80%
Doctors "always" treated them with courtesy and respect87%
Patients who gave a rating of "9" or "10" (high)79%
Staff "always" explained new medications76%
Nurses "always" explained things so they could understand77%
Nurses "always" listened carefully79%
Nurses "always" treated them with courtesy and respect88%
"Always" quiet at night53%
"YES", patients would definitely recommend the hospital83%
Staff "always" explained possible side effects50%
Yes, staff "did" give patients information about possible symptoms90%

Original Medicare doctor bills

$4,279

Medicare paid this office $4,279 for 29 people. Most of that is long return visits and Botox.

This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.

Largest Original Medicare bills
Long return visit (40+ min)19$3,451$102

Procedures year by year

Procedures billed to Original Medicare by year
Procedure201920202021202220232024
Biopsy and aspiration of bone marrow sample for diagnosis–––2064–

Times billed to Original Medicare each year. A blank year means fewer than 11 people had it, or none: Medicare does not publish smaller counts. Medicare Advantage patients are not included.

Who their Medicare patients are

29 Original Medicare patients in 2024. Average age 72 · 85 and older 0% · Women 48% · Also on Medicaid 0% · Health risk score 3.59. Sicker patients than 9 in 10 peers; the typical nurse practitioner clinician is at 1.42.

Conditions among them: High blood pressure 75% · Coronary heart disease 41%.

The office billed $34,680, Medicare allowed $5,705 and paid $4,279; for 47 services of 5 kinds.

Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.

Year by year

Original Medicare by year
20242947723.59$34,680$4,279
2023110190723.50$143,915$16,696
202233193692.77$28,738$4,292
20214555584.78$14,689$3,424
2020129198576.51$49,294$11,116
2019203361576.42$90,361$20,752
2018199366566.04$95,740$22,105
2017215350546.13$101,335$23,368
2016180294536.19$77,923$18,094
201581127558.11$37,247$8,242
20141731612.21$14,255$2,437

Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.

See the services billed each year

2023: 2 services

Original Medicare services billed in 2023
Long return visit (40+ min)46$11,859$111
Biopsy and aspiration of bone marrow sample for diagnosis61$3,701$58

2022: 2 services

Original Medicare services billed in 2022
Long return visit (40+ min)15$2,505$125
Biopsy and aspiration of bone marrow sample for diagnosis20$1,620$81

2021: 2 services

Original Medicare services billed in 2021
Short return visit (20+ min)21$1,021$46
Return visit (30+ min)13$850$57

2020: 4 services

Original Medicare services billed in 2020
Return visit (30+ min)66$4,123$51
Telephone medical discussion with physician, 21-30 minutes41$2,892$59
Initial hospital care with moderate level of medical decision making at least 75 minutes12$1,796$150
Telephone medical discussion with physician, 11-20 minutes21$885$38

2019: 2 services

Original Medicare services billed in 2019
Return visit (30+ min)171$15,071$54
Subsequent hospital care with moderate levelof medical decision making at least 35 minutes20$1,861$53

2018: 2 services

Original Medicare services billed in 2018
Return visit (30+ min)174$16,058$55
Long return visit (40+ min)38$3,435$76

2017: 2 services

Original Medicare services billed in 2017
Long return visit (40+ min)147$14,851$78
Return visit (30+ min)105$8,297$54

2016: 2 services

Original Medicare services billed in 2016
Return visit (30+ min)117$11,053$56
Long return visit (40+ min)73$6,690$77

2015: 2 services

Original Medicare services billed in 2015
Return visit (30+ min)65$4,462$56
Long return visit (40+ min)29$3,227$81

Medicaid work

$584 in 2019

Medicaid paid $584 for 18 billed services this clinician did in 2019, up to 13 people in a month for one service.

Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.

Largest Medicaid services in 2019
Return visit (30+ min)18$584
Medicaid work by year
201918113$584

Drugs they prescribed that Part D paid

$86,195

Pharmacies billed $86,195 in 2024.

This is pharmacy cost, not the office bill, and not what patients paid.

128 generic and 20 brand-name prescriptions · $86,195 in drug cost · 15 antibiotic prescriptions to 13 people.

Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.

Largest Part D drug costs
Acyclovir12$591$26

Year by year

Part D prescribing by year
202414840None14%$86,195
202325064None8%$88,992
2022193626% (12)8%$57,056
2021184508% (15)None$17,807
202025462NoneNone$109,185
20194391083% (13)None$50,614
2018365983% (12)None$41,633
2017338946% (20)None$50,540
2016238796% (14)None$12,954
201525947NoneNone$28,771
2014228316% (14)None$19,573
201317519None18%$27,781

Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.

See the drugs prescribed each year

2023: 4 drugs

Part D drugs prescribed in 2023
Acyclovir29$437$15
Gabapentin19$403$21
Sulfamethoxazole-Trimethoprim18$103$6
Zolpidem13$74$6

2022: 4 drugs

Part D drugs prescribed in 2022
Atovaquone12$23,157$1,930
Valacyclovir12$401$33
Pregabalin11$178$16
Sulfamethoxazole-Trimethoprim12$64$5

2021: 6 drugs

Part D drugs prescribed in 2021
Tacrolimus12$1,212$101
Nifedipine Er12$863$72
Hydrocodone-Acetaminophen11$352$32
Pregabalin14$295$21
Sulfamethoxazole-Trimethoprim24$129$5
Zolpidem13$127$10

2020: 7 drugs

Part D drugs prescribed in 2020
Tacrolimus30$18,564$619
Atovaquone16$16,277$1,017
Valganciclovir21$15,297$728
Mycophenolate Mofetil20$2,803$140
Carvedilol25$270$11
Sulfamethoxazole-Trimethoprim26$199$8
Amlodipine Besylate13$98$8

2019: 12 drugs

Part D drugs prescribed in 2019
Valganciclovir23$22,209$966
Entecavir11$4,395$400
Nifedipine Er12$1,585$132
Fludrocortisone Acetate15$500$33
Carvedilol39$471$12
Sulfamethoxazole-Trimethoprim52$234$4
Amlodipine Besylate34$233$7
Pantoprazole19$226$12
Gabapentin15$223$15
Tamsulosin15$213$14
Prednisone19$181$10
Famotidine13$169$13

2018: 10 drugs

Part D drugs prescribed in 2018
Valganciclovir12$12,479$1,040
Nifedipine Er11$932$85
Tacrolimus12$583$49
Tamsulosin12$361$30
Carvedilol35$330$9
Sulfamethoxazole-Trimethoprim53$188$4
Pantoprazole17$184$11
Amlodipine Besylate28$125$4
Hydrocodone-Acetaminophen12$89$7
Furosemide14$37$3

2017: 10 drugs

Part D drugs prescribed in 2017
Nifedipine Er20$670$34
Fludrocortisone Acetate13$350$27
Metoprolol16$306$19
Carvedilol35$199$6
Sulfamethoxazole-Trimethoprim47$150$3
Omeprazole11$114$10
Pantoprazole16$106$7
Hydrocodone-Acetaminophen14$101$7
Prednisone14$77$5
Amlodipine Besylate12$43$4

2016: 4 drugs

Part D drugs prescribed in 2016
Carvedilol24$231$10
Omeprazole12$97$8
Sulfamethoxazole-Trimethoprim21$83$4
Hydrocodone-Acetaminophen12$81$7

2015: 6 drugs

Part D drugs prescribed in 2015
Ursodiol25$5,671$227
Fluconazole16$1,208$75
Acyclovir54$684$13
Omeprazole19$169$9
Ranitidine15$107$7
Carvedilol12$64$5

2014: 4 drugs

Part D drugs prescribed in 2014
Ursodiol13$1,226$94
Acyclovir77$1,140$15
Fluconazole15$791$53
Prochlorperazine Maleate15$78$5

2013: 4 drugs

Part D drugs prescribed in 2013
Ursodiol20$733$37
Lansoprazole11$684$62
Acyclovir34$674$20
Fluconazole12$380$32

Money from drug and device companies

$89 in 2025

Industry payments by year
202534None$89
202312None$116
202111None$95

Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.

A payment is not proof that care is biased.

Payments by company
CelgeneBreyanzi$58
2 payments
  • Meals for Breyanzi · 2025-07-29 · $30
  • Meals for Breyanzi · 2025-07-08 · $29
Janssen BiotechDarzalex$16
1 payment
  • Meals for Darzalex · 2025-05-29 · $16
Daiichi SankyoEnhertu$14
1 payment
  • Meals for Enhertu · 2025-09-23 · $14
See all 4 published payments
Every published payment
Daiichi SankyoMeals · 2025-09-23Enhertu$14
CelgeneMeals · 2025-07-29Breyanzi$30
CelgeneMeals · 2025-07-08Breyanzi$29
Janssen BiotechMeals · 2025-05-29Darzalex$16
See earlier years (2023, 2021)

2023: $116

Payments by company in 2023
IncyteNone$116
2 payments
  • Meals · 2023-11-01 · $51
  • Education · 2023-03-21 · $65

2021: $95

Payments by company in 2021
CelgeneNone$95
1 payment
  • Meals · 2021-10-27 · $95

Checkups this office reported

Medicare did not publish checkup rates for this clinician.

Medicare’s overall office score
73.6 / 100
Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.

Professional record

NPI
1184990699
Licence
IL 209012838, MI 4704267088Illinois 209012838: Active
Video visits
Lists video visits
Gender
Female
More record details
Sole proprietor
No
Taxonomy
Nurse practitioner (363L00000X)
Mailing address
300 Pasteur Dr, Stanford, CA, 94305
NPI first listed
2012-03-29
NPI last updated
2024-06-06
NPI record certified
2024-06-06

This is when the NPI record was last certified, not a medical board exam.